These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29503965)

  • 21. HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
    Malik K; Welch RJ; Shields CL
    Retin Cases Brief Rep; 2020; 14(4):368-371. PubMed ID: 29443806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late recurrence of tumor necessitating enucleation in an adult onset retinoblastoma.
    Khetan V; Mathur G; Kumar SK; Gopal L
    Ophthalmic Genet; 2013; 34(1-2):87-9. PubMed ID: 22950453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
    Sultan I; Hajja Y; Nawaiseh I; Mehyar M; Deebajah R; Jaradat I; Yousef YA
    Ophthalmic Genet; 2016 Jun; 37(2):209-13. PubMed ID: 26760494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
    Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
    J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma.
    Jacobsen BH; Berry JL; Jubran R; Kim JW
    Ocul Oncol Pathol; 2015 Dec; 2(2):76-9. PubMed ID: 27171650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of massive orbital involvement of intraocular retinoblastoma.
    Kiratli H; Bilgiç S; Ozerdem U
    Ophthalmology; 1998 Feb; 105(2):322-6. PubMed ID: 9479294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
    Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
    Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral Retinoblastoma Presenting with Unilateral Phthisis.
    Maka E; Csákány B; Tóth J
    J Pediatr Ophthalmol Strabismus; 2009 Nov; ():. PubMed ID: 19928701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of diode laser in the treatment of intraocular tumors: preliminary report].
    Kociecki J; Pecold K
    Klin Oczna; 1999; 101(1):23-7. PubMed ID: 10401210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes.
    Fabian ID; Naeem Z; Stacey AW; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
    Am J Ophthalmol; 2017 Jul; 179():137-144. PubMed ID: 28501391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
    Liu Y; Zhang X; Liu F; Wang KL
    Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current treatment of retinoblastoma.
    De Potter P
    Curr Opin Ophthalmol; 2002 Oct; 13(5):331-6. PubMed ID: 12218465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conservative treatments of intraocular retinoblastoma.
    Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
    Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras.
    Camp DA; Dalvin LA; Schwendeman R; Lim LS; Shields CL
    Indian J Ophthalmol; 2019 Dec; 67(12):1997-2004. PubMed ID: 31755437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hand-held Optical Coherence Tomography Monitoring of Submillimeter Retinoblastoma Treated with Indocyanine Green-enhanced Transpupillary Therapy.
    Spencer MA; Welch RJ; Shields CL
    Middle East Afr J Ophthalmol; 2018; 25(2):108-110. PubMed ID: 30122857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strabismus in retinoblastoma survivors with long-term follow-up.
    Fabian ID; Stacey AW; Naeem Z; Onadim Z; Chowdhury T; Duncan C; Sagoo MS; Reddy MA
    J AAPOS; 2018 Aug; 22(4):276.e1-276.e7. PubMed ID: 30009948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indocyanine Green-Enhanced Thermotherapy for Retinoblastoma.
    Al-Haddad CE; Abdulaal M; Saab RH; Bashshur ZF
    Ocul Oncol Pathol; 2015 Feb; 1(2):77-82. PubMed ID: 27231688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.